Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical Announces ''First-In-Man'' HIV/AIDS Treatment Study
July 16th, 2008
Aethlon Medical, Inc. (OTCBB:AEMD) announced that it has entered into an agreement to initiate the "first-in-man" clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV) which causes Acquired Immune Deficiency Syndrome (AIDS). The Aethlon Hemopurifier(R) is a medical device created to provide real-time therapeutic filtration of infectious viruses and immunosuppressive proteins. The Hemopurifier(R) holds promise to extend the lives of AIDS patients by removing HIV strains that cause drug failure and reducing the presence of viral proteins that kill-off immune cells. The clinical study was approved by the Institutional Ethics Committee at the Jattinder Gambhir...
Source: Vaccine Weekly (2008-07-16)
|
